Cellectar Biosciences - 19 Year Stock Price History | CLRB
- The all-time high Cellectar Biosciences stock closing price was 10342800.00 on November 30, 2005.
- The Cellectar Biosciences 52-week high stock price is 4.45, which is 46.9% above the current share price.
- The Cellectar Biosciences 52-week low stock price is 1.33, which is 56.1% below the current share price.
- The average Cellectar Biosciences stock price for the last 52 weeks is 2.56.
Cellectar Biosciences Historical Annual Stock Price Data | ||||||
---|---|---|---|---|---|---|
Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
2024 | 3.5712 | 2.8600 | 4.2400 | 2.7100 | 3.0300 | 9.39% |
2023 | 1.9208 | 1.6300 | 2.9100 | 1.3500 | 2.7700 | 61.99% |
2022 | 4.3403 | 7.0990 | 7.8000 | 1.2700 | 1.7100 | -74.25% |
2021 | 13.0324 | 20.7000 | 25.0000 | 6.1100 | 6.6400 | -68.08% |
2020 | 16.1534 | 24.9000 | 31.7000 | 10.3000 | 20.8000 | -7.56% |
2019 | 20.5260 | 15.8000 | 28.5000 | 10.6000 | 22.5000 | 45.16% |
2018 | 70.8377 | 137.0000 | 137.0000 | 12.9000 | 15.5000 | -88.69% |
2017 | 172.6918 | 128.0000 | 266.0000 | 112.0000 | 137.0000 | 12.30% |
2016 | 310.3655 | 732.0000 | 761.5000 | 105.0000 | 122.0000 | -83.40% |
2015 | 2506.5952 | 3060.1000 | 3550.0000 | 685.0000 | 735.0000 | -76.21% |
2014 | 5525.4690 | 7600.0000 | 8400.0000 | 1989.5000 | 3090.0000 | -58.24% |
2013 | 9109.5238 | 14800.0000 | 15800.0000 | 6000.0000 | 7400.0000 | -50.00% |
2012 | 19215.2000 | 9000.0000 | 40000.0000 | 8600.0000 | 14800.0000 | 68.18% |
2011 | 43157.9365 | 122400.0000 | 153000.0000 | 7400.0000 | 8800.0000 | -90.41% |
2010 | 1136328.5714 | 9088200.0000 | 9088200.0000 | 61200.0000 | 91800.0000 | -98.82% |
2009 | 2159971.4286 | 1438200.0000 | 7772400.0000 | 1040400.0000 | 7772400.0000 | 440.43% |
2008 | 1585878.2609 | 1866600.0000 | 2448000.0000 | 673200.0000 | 1438200.0000 | -21.67% |
2007 | 2608558.5657 | 2754000.0000 | 4161600.0000 | 1315800.0000 | 1836000.0000 | -31.82% |
2006 | 3745756.9721 | 5814000.0000 | 6915600.0000 | 1927800.0000 | 2692800.0000 | -56.44% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $0.098B | $0.000B |
Cellectar Biosciences, Inc. is developing agents to detect, treat and monitor a broad spectrum of cancers. It uses a novel phospholipid ether platform technology as a targeted delivery and retention vehicle. Cellectar Biosciences Inc., formerly known as Novelos Therapeutics, Inc., is headquartered in Madison, Wisconsin. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $186.584B | 24.49 |
Stryker (SYK) | United States | $127.690B | 31.66 |
Boston Scientific (BSX) | United States | $107.347B | 34.19 |
Medtronic (MDT) | Ireland | $105.881B | 14.99 |
EssilorLuxottica (ESLOY) | France | $98.566B | 0.00 |
Lonza Group Ag (LZAGY) | Switzerland | $43.036B | 0.00 |
Haleon (HLN) | United Kingdom | $38.584B | 30.18 |
ResMed (RMD) | United States | $32.074B | 30.08 |
Terumo (TRUMY) | Japan | $24.746B | 34.95 |
Zimmer Biomet Holdings (ZBH) | United States | $24.522B | 15.79 |
Baxter (BAX) | United States | $20.379B | 14.86 |
Koninklijke Philips (PHG) | Netherlands | $19.567B | 15.61 |
Insulet (PODD) | United States | $11.637B | 61.10 |
Smith & Nephew SNATS (SNN) | United Kingdom | $10.689B | 0.00 |
Demant (WILYY) | Denmark | $9.943B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $7.869B | 23.44 |
BellRing Brands (BRBR) | United States | $7.379B | 39.68 |
Haemonetics (HAE) | United States | $4.621B | 23.63 |
Lantheus Holdings (LNTH) | United States | $4.494B | 11.60 |
Perrigo (PRGO) | Ireland | $4.328B | 12.38 |
GN Store Nord (GNNDY) | Denmark | $4.065B | 26.32 |
Envista Holdings (NVST) | United States | $3.504B | 13.33 |
Prestige Consumer Healthcare (PBH) | United States | $3.499B | 16.54 |
QuidelOrtho (QDEL) | United States | $2.651B | 9.62 |
Neogen (NEOG) | United States | $2.630B | 25.29 |
Green Thumb Industries (GTBIF) | United States | $2.571B | 81.47 |
ICU Medical (ICUI) | United States | $2.311B | 17.24 |
TG Therapeutics (TGTX) | United States | $2.082B | 673.50 |
Maravai LifeSciences Holdings (MRVI) | United States | $1.936B | 0.00 |
Owens & Minor (OMI) | United States | $1.922B | 18.45 |
Agios Pharmaceuticals (AGIO) | United States | $1.770B | 0.00 |
Verano Holdings (VRNOF) | United States | $1.697B | 0.00 |
LeMaitre Vascular (LMAT) | United States | $1.469B | 48.49 |
InMode (INMD) | Israel | $1.439B | 7.45 |
National Vision Holdings (EYE) | United States | $1.400B | 43.61 |
AdaptHealth (AHCO) | United States | $1.324B | 9.96 |
Warby Parker (WRBY) | United States | $1.271B | 0.00 |
AtriCure (ATRC) | United States | $1.121B | 0.00 |
MacroGenics (MGNX) | United States | $0.911B | 0.00 |
Canopy Growth (CGC) | Canada | $0.893B | 0.00 |
BioLife Solutions (BLFS) | United States | $0.794B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.709B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.682B | 14.73 |
Evolus (EOLS) | United States | $0.662B | 0.00 |
Jin Medical (ZJYL) | China | $0.626B | 0.00 |
Quanterix (QTRX) | United States | $0.595B | 0.00 |
Valneva SE (VALN) | France | $0.532B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.516B | 11.17 |
PetIQ (PETQ) | United States | $0.486B | 18.16 |
TerrAscend (TSNDF) | Canada | $0.486B | 0.00 |
ZimVie (ZIMV) | United States | $0.431B | 26.37 |
Biote (BTMD) | United States | $0.411B | 3.91 |
OraSure Technologies (OSUR) | United States | $0.407B | 6.73 |
Surmodics (SRDX) | United States | $0.373B | 40.26 |
Aurora Cannabis (ACB) | Canada | $0.365B | 0.00 |
Zynex (ZYXI) | United States | $0.361B | 41.52 |
Viemed Healthcare (VMD) | United States | $0.322B | 31.96 |
Cerus (CERS) | United States | $0.310B | 0.00 |
Sanara MedTech (SMTI) | United States | $0.279B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.250B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.237B | 14.65 |
Organigram Holdings (OGI) | Canada | $0.192B | 0.00 |
Veru (VERU) | United States | $0.186B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.183B | 0.00 |
Omeros (OMER) | United States | $0.183B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.170B | 0.00 |
High Tide (HITI) | Canada | $0.161B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.156B | 0.00 |
Eagleford Energy (GRUSF) | United States | $0.144B | 72.36 |
FitLife Brands (FTLF) | United States | $0.132B | 21.28 |
Jushi Holdings (JUSHF) | United States | $0.131B | 0.00 |
InterCure (INCR) | Israel | $0.121B | 20.46 |
Fonar (FONR) | United States | $0.103B | 8.84 |
MariMed (MRMD) | United States | $0.100B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.100B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.092B | 0.00 |
Safety Shot (SHOT) | United States | $0.082B | 0.00 |
Chimerix (CMRX) | United States | $0.080B | 0.00 |
Brainsway (BWAY) | Israel | $0.079B | 0.00 |
Zevia PBC (ZVIA) | United States | $0.058B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.054B | 3.53 |
Apyx Medical (APYX) | United States | $0.050B | 0.00 |
Cytosorbents (CTSO) | United States | $0.044B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.043B | 0.00 |
ImmuCell (ICCC) | United States | $0.040B | 0.00 |
United-Guardian (UG) | United States | $0.038B | 14.77 |
Bright Green (BGXX) | United States | $0.038B | 0.00 |
Modular Medical (MODD) | United States | $0.035B | 0.00 |
Exagen (XGN) | United States | $0.024B | 0.00 |
Nephros (NEPH) | United States | $0.023B | 0.00 |
FSD PHARMA (HUGE) | Canada | $0.019B | 0.00 |
Flora Growth (FLGC) | United States | $0.017B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.017B | 0.00 |
Agape ATP (ATPC) | $0.017B | 0.00 | |
Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
GlucoTrack (GCTK) | United States | $0.012B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.010B | 71.82 |
NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
Sharps Technology (STSS) | United States | $0.004B | 0.00 |
Senestech (SNES) | United States | $0.004B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
Lucy Scientific Discovery (LSDI) | Canada | $0.001B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
Smart For Life (SMFL) | United States | $0.000B | 0.00 |
Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
SNDL (SNDL) | Canada | $0.000B | 0.00 |